Core Viewpoint - Tuo Yun Bio (01332) has seen a significant stock price increase of nearly 900% since October 30, with a peak of 0.75 HKD and a current price of 0.56 HKD, driven by a strategic partnership agreement for substantial product procurement [1] Company Summary - Shanxi Tuo Yun Bio Technology Co., Ltd., a wholly-owned subsidiary of Tuo Yun Bio Group, has signed a strategic cooperation agreement with a sales consortium for the procurement of no less than 1 billion RMB worth of Rhizoclonium algae products from 2026 to 2028 [1] - The company is recognized as a key project and high-tech enterprise in Shanxi Province, having established the world's first large-scale production facility for Rhizoclonium algae with an investment of 370 million RMB [1] - The facility, located in Lucheng District, is designed to produce 20,000 tons of Rhizoclonium algae powder annually, with the first phase of 4,000 tons having commenced production three months ahead of schedule in March 2023 [1] Industry Summary - The strategic partnership highlights the growing demand for microalgae products, which are increasingly recognized for their potential in various applications, including health and nutrition [1] - The use of proprietary acetic acid fermentation technology in a closed automated production process addresses traditional challenges in the microalgae industry, such as land use and pollution [1]
港股异动 | 透云生物(01332)再涨超81% 近三日累涨近9倍 山西透云生物签约10亿元莱茵衣藻订单